ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.430,58
0,71%
S&P 500
6.059,49
0,79%
Dow Jones
44.829,15
0,26%
Euro vs US Dollar
1,04288
-0,14%
Bitcoin
102.818,49
0,72%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Omthera Pharmaceuticals, Inc. (MM) (OMTH) Börsenkurse

Omthera Pharmaceuticals, Inc. (MM)

Omthera Pharmaceuticals, Inc. (MM) (OMTH)

NASDAQ
13,30
0,00
( 0,00% )
Aktualisiert: 01:00:00
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
13,30
Gebot
0,00
Fragen
0,00
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Handelsende
13,30
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

OMTH Neueste Nachrichten

Weitere Nachrichten

Omthera Stockholders Approve Acquisition by AstraZeneca

Omthera Stockholders Approve Acquisition by AstraZeneca PR Newswire PRINCETON, N.J., July 16, 2013 PRINCETON, N.J., July 16, 2013 /PRNewswire/ -- The stockholders of Omthera Pharmaceuticals, Inc...

16 Juli 2013
PR Newswire (US)

Omthera Pharmaceuticals Announces NDA Submission for Epanova™ for the Treatment of Patients with Very High Triglycerides

Omthera Pharmaceuticals Announces NDA Submission for Epanova™ for the Treatment of Patients with Very High Triglycerides PR Newswire PRINCETON, N.J., July 9, 2013 PRINCETON, N.J., July 9, 2013...

09 Juli 2013
PR Newswire (US)

Omthera Pharmaceuticals Announces Termination Of Antitrust Waiting Period

Omthera Pharmaceuticals Announces Termination Of Antitrust Waiting Period PR Newswire PRINCETON, N.J., June 27, 2013 PRINCETON, N.J., June 27, 2013 /PRNewswire/ -- Omthera Pharmaceuticals, Inc...

27 Juni 2013
PR Newswire (US)

Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders

Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders PR Newswire PRINCETON, N.J., June 13, 2013 PRINCETON, N.J., June 13, 2013 /PRNewswire/...

13 Juni 2013
PR Newswire (US)

OMTHERA PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors of Claims of Breaches of Fiduciary Duty by Board

NEW YORK, June 4, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors of Omthera Pharmaceuticals, Inc. ("Omthera" or the "Company") (Nasdaq:OMTH) of claims of breaches of fiduciary duty...

04 Juni 2013
GlobeNewswire Inc.

Rigrodsky & Long, P.A. Investigates Omthera Pharmaceuticals, Inc. Buyout

AstraZeneca PLC offers $12.70 per share to Omthera Pharmaceuticals shareholders

31 Mai 2013
Business Wire

Omthera Pharmaceuticals, Inc. Stockholders Seeking More Money, Information in Buyout Should Contact Deans & Lyons Law Firm

Omthera Pharmaceuticals, Inc. Stockholders Seeking More Money, Information in Buyout Should Contact Deans & Lyons Law Firm PR Newswire DALLAS, May 30, 2013 DALLAS, May 30, 2013 /PRNewswire/...

31 Mai 2013
PR Newswire (US)

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Omthera Pharmaceuticals, Inc.

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Omthera Pharmaceuticals, Inc. (“Omthera” or the “Company”) (Nasdaq:...

30 Mai 2013
Business Wire
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

OMTH - Frequently Asked Questions (FAQ)

What is the current OMTHERA PHARMACEUTICALS, INC. share price?
The current share price of OMTHERA PHARMACEUTICALS, INC. is US$ 13,30
What is the 1 year trading range for OMTHERA PHARMACEUTICALS, INC. share price?
OMTHERA PHARMACEUTICALS, INC. has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SLXNSilexion Therapeutics Corporation
US$ 1,1801
(103,47%)
180,47M
RNAZTransCode Therapeutics Inc
US$ 12,8499
(88,14%)
21,04M
YIBOPlanet Image International Ltd
US$ 4,84
(57,14%)
50,08M
TRIBTrinity Biotech PLC
US$ 1,12
(47,37%)
101,02M
HEPAHepion Pharmaceuticals Inc
US$ 0,2281
(38,24%)
238,73M
STSSSharps Technology Inc
US$ 0,4218
(-71,11%)
12,51M
LPTXLeap Therapeutics Inc
US$ 0,6585
(-70,73%)
8,37M
SABSSAB Biotherapeutics Inc
US$ 2,23
(-48,85%)
952,14k
INKTMiNK Therapeutics Inc
US$ 4,575
(-48,24%)
104,41k
MGOLMGO Global Inc
US$ 0,1675
(-40,81%)
16,26M
NVDANVIDIA Corporation
US$ 124,15
(4,84%)
276,52M
HEPAHepion Pharmaceuticals Inc
US$ 0,2281
(38,24%)
238,74M
SLXNSilexion Therapeutics Corporation
US$ 1,185
(104,31%)
180,49M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,5166
(25,36%)
152,3M
TRIBTrinity Biotech PLC
US$ 1,115
(46,71%)
101,02M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
OMTH
OMTHERA PHARMACEUTICALS, INC.
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten